Summary by Futu AI
The company did not increase or decrease its regulated/registered share capital during March 2024 at 7,000,000,000 shares with a face value of $0.0001 per share and a total regulated/registered share capital of $700,000, according to the latest Securities Change Monthly Report filed on March 31, 2024. The report also noted that under the share option plan adopted on June 6, 2019, the company wrote off 100,000 share options in March, bringing the number of stock options outstanding at the end of the month to 11,306,841 shares. In addition, Charia Pharmaceutical-B repurchased and delisted 32,063,000 shares of ordinary shares on March 5, which were repurchased between December 2023 and February 2024. The total decrease in ordinary shares for the month was 32,063,000 shares. The change was reported to Hong Kong Trading and Settlement Limited on 2 April 2024.